Merger Announced
North Immunology and Aethlon Medical merger
Announced 17 Sep 2026 · NASDAQ: AEMD
Advisers
North Immunology
Target
Not disclosed
Acquirer
Not disclosed
Other advisers
- Financial adviser
- Legal adviser
- Target
- North Immunology
- Target based in
- United States
- Sector
- Biotech
In the league tables
Similar deals
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Lisata Therapeutics acquisition of Marea Therapeutics Sep 2026 · Biotech
- Xenetic Biosciences acquisition of Santersus AG Sep 2026 · Medtech
- Leyden Labs acquisition of RIGImmune Sep 2026 · Biotech
- Holiferm and Organica UK merger Sep 2026 · Chemicals
Sources
- 17 Sep 2026 Gibson Dunn Advises North Immunology on Merger With Aethlon Medical, Concurrent Private Placement gibsondunn.com
- 17 Sep 2026 Press release (PR Newswire), Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis prnewswire.com
